Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 701–800 of 1,000
Pro-Resolving Molecules—New Approaches to Treat Sepsis?
Buechler, C., Pohl, R., & Aslanidis, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030476 · Cited by 38
“Of note, inflammatory lipids released early during inflammation induce production of pro-resolving lipids such as lipoxins which down-modulate inflammatory response and resolve inflammation [35].”
BackgroundSpecialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
del Campo, L. S. D., Rodrigues‐Díez, R., Salaíces, M., Briones, A. M., & García‐Redondo, A. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073592 · Cited by 39
“Subsequently, they are replaced by SPMs, which limit further pol‐ ymorphonuclear cell (PMN) infiltration and initiate resolution [12,36,37] (Figure 2).”
BackgroundNandivada, P., Cowan, E. A., Carlson, S. J., Chang, M. I., Gura, K. M., & Puder, M. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.02.008 · Cited by 37
“In addition to the decreased initiation of the inflammatory response, a new class of PUFA derivatives has been shown to play a role in the active resolution of inflammation through production of specialized pro-resolving mediators (SPM) [59–60].”
Zhai, B., Yang, H., Mancini, A., He, Q., Antoniou, J., & Di Battista, J. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107623 · Cited by 29
Aswad, M., Assi, S., Schif‐Zuck, S., & Ariel, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1502542 · Cited by 39
Divergent roles of prostacyclin and PGE2 in human tendinopathy
Bergqvist, F., Carr, A. J., Wheway, K., Watkins, B., Oppermann, U. C. T., Jakobsson, P., & Dakin, S. G. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1855-5 · Cited by 36
“Moreover, PGE2 generated during inflammation is a requirement to trigger endogenous tissue resolution responses [40].”
BackgroundAlqahtani, S., Kobos, L. M., Xia, L., Ferreira, C. R., Franco, J., Du, X., & Shannahan, J. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00818 · Cited by 36
“Lipid mediators of inflammation are known to be modified in MetS contributing to the chronic inflammatory state associated with the condition (16).”
BackgroundSpecialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis
Zahoor, I., & Giri, S. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08796-4 · Cited by 39
The p53 Family: A Role in Lipid and Iron Metabolism
Laubach, K., Zhang, J., & Chen, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715974 · Cited by 37
Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction
Baral, P. K., Amin, M. T., Rashid, M. M. O., & Hossain, M. S. (2021) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-021-00213-x · Cited by 36
“Similarly, series 4 eicosanoids (LTB4, LTC4, and contrast, 5-lipoxygenase inhibition of PGE2 decreases the pro-inflammatory series 4 LT level (Levy et al. 2001).”
BackgroundMADERNA, P., & Godson, C. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.004 · Cited by 38
“[9] B.”
BackgroundInfluentialGene expression profiling of peripheral mononuclear cells in lame dairy cows with foot lesions
de Almeida, P. E., Weber, P. S. D., Burton, J. L., Tempelman, R. J., Steibel, J. P., & Zanella, A. J. (2007) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.06.028 · Cited by 37
Neutrophils Accelerate Macrophage-Mediated Digestion of Apoptotic Cells In Vivo as Well as In Vitro
Iyoda, T., Nagata, K., Akashi, M., & Kobayashi, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3475 · Cited by 37
Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
Yin, P., Wei, Y., Wang, X., Zhu, M., & Feng, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00617 · Cited by 35
“In the first pathway, Lipoxin A4 (LXA4) and lipoxin B4 (LXB4) are produced by the oxygenation of AA by 15-LOX and 5-LOX, and then by enzymatic hydrolysis in mucosal tissues (137).”
BackgroundSchreurs, M., Suttorp, C. M., Mutsaers, H. A. M., Kuijpers‐Jagtman, A. M., den Hoff, J. W. V., Ongkosuwito, E. M., Monroy, P. L. C., & Wagener, F. A. D. T. G. (2019) · Medicinal Research Reviews · doi:10.1002/med.21594 · Cited by 35
Sundaram, T. S., Giromini, C., Rebucci, R., Pistl, J., Bhide, M. R., & Baldi, A. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00690-7 · Cited by 33
“resolvins (Rv)Es and DHA such as the D-series RvDs, maresins (MaRs), and protectins (PDs) act as antagonists of inflammation [20, 52, 53, 55] [Fig.”
BackgroundIn vitro and in vivo activities of leukotriene B4-loaded biodegradable microspheres
Nicolete, R., Lima, K. D. M., Júnior, J. M. R., Dias‐Baruffi, M., de Medeiros, A. I., Bentley, M. V. L. B., Silva, C. L., & Faccioli, L. H. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.10.007 · Cited by 32
“It was demonstrate that in vivo LTB4 injection induces rapid neutrophils [24,25] and eosinophils [2] recruitment.”
BackgroundLipopolysaccharide-induced Cyclooxygenase-2 Expression in Mouse Transformed Clara Cells
Britt, R. D., Locy, M. L., Tipple, T. E., Nelin, L. D., & Rogers, L. K. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000337602 · Cited by 32
Hung, N. D., Kim, M. R., & Sok, D. (2010) · Inflammation · doi:10.1007/s10753-010-9218-z · Cited by 35
“During the time course of inflammation, there is switching of the lipid mediator class from pro-inflammatory prostaglandins (PGs) and leukotriene (LTs) to the biosynthesis of anti-inflammatory mediators, such as lipoxins [2], E-series resolvins, and protectin D1 [1].”
BackgroundCurrent knowledge of the implication of lipid mediators in psoriasis
Simard, M., Morin, S., Ridha, Z., & Pouliot, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961107 · Cited by 32
Contextual functions of antigen‐presenting cells in the gastrointestinal tract
Grainger, J. R., Askenase, M. H., Guimont‐Desrochers, F., da Fonseca, D. M., & Belkaid, Y. (2014) · Immunological Reviews · doi:10.1111/imr.12167 · Cited by 33
“Notably, in resolving inflammatory exudates, prostaglandin E2 and prostaglandin D2 stimulate the production of a functional enzyme for lipoxin production in neutrophils (136).”
BackgroundPiotrowska-Tomala, K. K., Siemieniuch, M., Szóstek-Mioduchowska, A. Z., Korzekwa, A. J., Wocławek-Potocka, I., Galvão, A. M., Okuda, K., & Skarzynski, D. J. (2012) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2012.04.005 · Cited by 35
A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood
Mazaleuskaya, L. L., Lawson, J. A., Li, X., Grant, G. R., Mesaros, C., Großer, T., Blair, I. A., Ricciotti, E., & FitzGerald, G. A. (2016) · JCI Insight · doi:10.1172/jci.insight.87031 · Cited by 32
“A more likely explanation is that it may be the product of eosinophil 15-LOX, activated by formation of COX-2–derived eicosanoids in monocytes (31).”
Neutrophil as a multifunctional relay in immune system
Dolgushin, I. I., Анатольевна, М. Е., Savochkina, A. Y., & Kuznetsova, E. K. (2019) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2019-1-9-38 · Cited by 44
Yamamoto, T., Miyata, J., Arita, M., Fukunaga, K., & Kawana, A. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.08.003 · Cited by 31
Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease
Zheng, D. J., Taka, M. A., & Heit, B. (2021) · Pathogens · doi:10.3390/pathogens10020134 · Cited by 33
Gallo, C. G., Fiorino, S., Posabella, G., Antonacci, D., Tropeano, A., Pausini, E., Pausini, C., Guarniero, T., Hong, W., Giampieri, E., et al. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106619 · Cited by 34
“tion, is not only associated with the amplification of this response in its initial step, but they also induce the enzyme 15-lipoxygenase (15-LOX) [28,30].”
Ivakine, E. A., Gulban, O., Mortin-Toth, S. M., Wankiewicz, E., Scott, C., Spurrell, D., Canty, A. J., & Danska, J. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2976 · Cited by 30
“These substrates are elevated during inflammation (50), and multiple lines of evidence suggest that they exhibit anti-inflammatory activities (32, 51, 52).”
BackgroundMotohashi, E., Kawauchi, H., Endo, H., Kondo, H., Kitasato, H., Kuramoto, H., Majima, M., Unno, N., & Hayashi, I. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.05.005 · Cited by 34
Eun, J. C., Moore, E. E., Banerjee, A. M., Kelher, M. R., Khan, S. Y., Elzi, D. J., McLaughlin, N. J. D., & Silliman, C. C. (2010) · Shock · doi:10.1097/shk.0b013e3181faceb3 · Cited by 35
“buffer-pretreated controls, n = 5) (18, 19) (Table 3).”
Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid
Hjorth, E., & Freund‐Levi, Y. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32835017cc · Cited by 36
“Interestingly, the proinflammatory COX product prostaglandin (PG) E2 has been shown to induce class-switching to lipoxin production in human PMNs, which was associated with increased expression of 15-LOX [75].”
BackgroundMaile, M. D., Standiford, T. J., Engoren, M., Stringer, K. A., Jewell, E. S., Rajendiran, T. M., Soni, T., & Burant, C. (2018) · Respiratory Research · doi:10.1186/s12931-018-0758-3 · Cited by 34
Kang, J., Lee, G., Jeung, E., & Yang, M. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507280584 · Cited by 33
“It has been reported that CLA decreases the synthesis of prostaglandins, in particular PGE2 (Li & Watkins, 1998), and PGE2 has been shown to have profound down regulatory effects on various inflammatory cells (Levy et al. 2001; Harris et al. 2002).”
BackgroundEnhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor
Uddin, M., Seumois, G., Lau, L. C. K., Rytilä, P. H., Davies, D. E., & Djukanović, R. (2007) · European Respiratory Journal · doi:10.1183/09031936.00144307 · Cited by 34
Cook, J. A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000196028.19746.42 · Cited by 31
“15-Lipoxygenase produces 15HETE and lipoxins (LX), which may be involved in inflammation resolution (11).”
BackgroundGromadzka, G., Czerwińska, J., Krzemińska, E., Przybyłkowski, A. M., & Litwin, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169034 · Cited by 35
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Tredicine, M., Mucci, M., Recchiuti, A., & Mattoscio, D. (2025) · FEBS Letters · doi:10.1002/1873-3468.70013 · Cited by 35
“On the contrary, the expression of COX-2 is mostly induced by inflammatory stimuli, hormones and growth factors, demonstrating its involvement in the onset of inflammation as well as in its resolution [21].”
Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine
Cioccari, L., Luethi, N., & Masoodi, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599853 · Cited by 32
Debris-stimulated tumor growth: a Pandora’s box?
Haak, V. M., Huang, S., & Panigrahy, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09998-8 · Cited by 36
The intriguing normal acute inflammatory response in mice lacking vimentin
Moisan, É., Chiasson, S., & Girard, D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03460.x · Cited by 37
Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction
Filep, J. G., Khreiss, T., & József, L. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.014 · Cited by 32
“Recent findings indicate temporal regulation of eicosanoid profiles, where switching to protective eicosanoids such as lipoxin A4 (LXA4) correlates with the onset of resolution of the acute inflammatory response [1].”
BackgroundCyclooxygenase-2 in newborn hyperoxic lung injury
Britt, R. D., Velten, M., Tipple, T. E., Nelin, L. D., & Rogers, L. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.012 · Cited by 30
“Increased levels of PGE2 have also been shown to influence “class switching” which is thought to be a pivotal event for the transition into inflammatory resolution pathways [47].”
BackgroundSoory, M. (2010) · Cancers · doi:10.3390/cancers2020670 · Cited by 31
Zhang, H., Lu, Y. W., Sun, G., Teng, F., Luo, N., Jiang, J., & Wen, A. (2017) · Critical Care · doi:10.1186/s13054-017-1757-3 · Cited by 30
“The development and resolution of inflammation may involve both proinflammatory and anti-inflammatory mechanisms [17, 18].”
BackgroundWarner, D. R., Liu, H., Dastidar, S. G., Warner, J. B., Prodhan, M. A. I., Yin, X., Zhang, X., Feldstein, A. E., Gao, B., Prough, R. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204119 · Cited by 35
Romano, M., Luciotti, G., Gangemi, S., Marinucci, F., Prontera, C., D’Urbano, E., & Davı̀, G. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000028823.53486.4a · Cited by 30
“LX possess potent anti-inflammatory activity in vivo, and temporal biosynthesis of LX, concurrent with spontaneous resolution, has been observed during exudate formation (Levy et al, 2001).”
BackgroundLevy, B. D. (2006) · Circulation · doi:10.1161/circulationaha.106.647925 · Cited by 30
Self-citationClasses of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis
Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 37
Meital, L. T., Sandow, S. L., Calder, P. C., & Russell, F. D. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.02.001 · Cited by 30
“inflammation to resolution [78] and PGE2 has been identified as a molecule that coordinates this response [79].”
5-Lipoxygenase Knockout Aggravated Apical Periodontitis in a Murine Model
Wu, Y. R., Sun, H., Yang, B., Liu, X., & Wang, J. (2017) · Journal of Dental Research · doi:10.1177/0022034517741261 · Cited by 29
Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
Shang, P., Zhang, Y., Ma, D., Hao, Y., Wang, X., Xin, M., Zhang, Y., Zhu, M., & Feng, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1691525 · Cited by 31
“Although researches have revealed that SPMs are synthesized from their precursors, it has also been reported that the production of pro-inflammatory mediators can be converted into the production of SPMs under certain circumstances, such as aspirin treatments or PG irritation [36]; this procedure is called ‘class swit…”
BackgroundEosinophils promote corneal wound healing via the 12/15‐lipoxygenase pathway
Ogawa, M., Ishihara, T., Isobe, Y., Kato, T., Kuba, K., Imai, Y., Uchino, Y., Tsubota, K., & Arita, M. (2020) · The FASEB Journal · doi:10.1096/fj.202000483r · Cited by 30
Impact of gut microbiota on plasma oxylipins profile under healthy and obesogenic conditions
Ávila‐Román, J., Arreaza‐Gil, V., Cortés-Espinar, A. J., Soliz‐Rueda, J. R., Mulero, M., Muguerza, B., Arola‐Arnal, A., Arola, L., & Torres‐Fuentes, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.035 · Cited by 34
Eicosanoid regulation of debris-stimulated metastasis
Deng, J., Yang, H., Haak, V. M., Yang, J., Kipper, F. C., Barksdale, C., Hwang, S. H., Gartung, A., Bielenberg, D. R., Subbian, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107771118 · Cited by 29
“Notably, PGE2 can induce lipid mediator class switching from proinflammatory eicosanoids to proresolving lipid mediators (105).”
Inflammation resolution in environmental pulmonary health and morbidity
Marzec, J. M., & Nadadur, S. S. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116070 · Cited by 30
Fatty Acid Transduction of Nitric Oxide Signaling
Cole, M. P., & Freeman, B. Α. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00011-3 · Cited by 30
Regulation of inflammation by lipid mediators in oral diseases
Sommakia, S., & Baker, O. J. (2016) · Oral Diseases · doi:10.1111/odi.12544 · Cited by 30
“As inflammation progresses, leukotriene generation by neutrophils decreases and 15-LOX- mediated synthesis of lipoxins commences prompting a lipid mediator class switch (Levy et al., 2001).”
Antiplatelet Therapy for Acute Respiratory Distress Syndrome
Chen, C., Lu, H.-C., Tung, Y., & Chen, W. (2020) · Biomedicines · doi:10.3390/biomedicines8070230 · Cited by 33
Resolving the problem of persistence in the switch from acute to chronic inflammation
Haworth, O., & Buckley, C. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710633105 · Cited by 29
Bauer, E., Metzler-Zebeli, B. U., Verstegen, M. W. A., & Mosenthin, R. (2011) · Nutrition Research Reviews · doi:10.1017/s0954422411000047 · Cited by 36
“tory eicosanoids through the induction of peroxisomal b-oxidation((140,141)).”
BackgroundDuality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop
Dietzold, J., Gopalakrishnan, A., & Salgame, P. (2015) · F1000Prime Reports · doi:10.12703/p7-29 · Cited by 31
Kim, W., Lee, H., Jang, J., Kim, S. H., Lee, Y., Hahn, Y., Ngo, H., Choi, Y., Joe, Y., Chung, H., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6754 · Cited by 33
“Recently, attention has been focused on a physiologic process termed lipid mediator class switching in the resolution phase of in-flammation, which promotes production of anti-inflammatory and proresolving eicosanoids (35).”
Quenching the fires: Pro-resolving mediators, air pollution, and smoking
Thatcher, T. H., Woeller, C. F., McCarthy, C. E., & Sime, P. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.001 · Cited by 30
Role of Tristetraprolin in the Resolution of Inflammation
Rappl, P., Brüne, B., & Schmid, T. (2021) · Biology · doi:10.3390/biology10010066 · Cited by 29
“Importantly, while resolution was considered a rather passive event for a long time, it is now widely accepted to be a highly regulated, complex process, which is initiated already early on during the course of inflammation [26,27].”
BackgroundBalta, M. G., Papathanasiou, E., & CHRISTOPOULOS, P. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632238 · Cited by 30
“This phenomenon, as was initially described in neutrophils gives rise to the synthesis of SPMs through pathways that are spatially and temporally distinct from those involved in the generation of pro-inflammatory lipid mediators (36, 37).”
BackgroundZaninelli, T. H., Fattori, V., & Verri, W. A., Jr. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729134 · Cited by 30
Hasan, R. A., O’Brien, E., & Mancuso, P. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182231644 · Cited by 32
“Persistent airway inflammation in asthma may result from excess proinflammatory mediators in the respiratory tissue or ongoing lipid peroxidation (16, 23, 24).”
BackgroundLee, Y. Y., Wong, C. K. C., Oger, C., Durand, T., Galano, J., & Lee, J. C. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1027199 · Cited by 29
“Both 15(S)- and 5(S)-HETE are reported to have modulating roles during inflammation [32].”
BackgroundCarlo, T., Kalwa, H., & Levy, B. D. (2013) · The FASEB Journal · doi:10.1096/fj.12-223982 · Cited by 28
Self-citationOxymetazoline Inhibits Proinflammatory Reactions: Effect on Arachidonic Acid-Derived Metabolites
Beck‐Speier, I., Dayal, N., Karg, E. W., Maier, K., Schumann, G., Semmler, M., & Koelsch, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093278 · Cited by 28
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice
Grazda, R., Seyfried, A. N., Maddipati, K. R., Fredman, G., & MacNamara, K. C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06705-7 · Cited by 31
Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch–Schönlein purpura
Wu, S., Liao, P., Yin, P., Zhang, Y.-M., & Dong, L. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.01.008 · Cited by 27
Control of Myeloid Cell Trafficking in Resolution
Norling, L. V., & Perretti, M. (2013) · Journal of Innate Immunity · doi:10.1159/000350612 · Cited by 29
Hurley, B. P., Pirzai, W., Mumy, K. L., Gronert, K., & McCormick, B. A. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00147.2010 · Cited by 33
“Despite their structural similarity, eicosanoids exhibit a wide range of distinct activities in the context of inflammation (7, 10, 19, 27, 33).”
BackgroundSelf-citationSpecialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
Philippe, R., & Urbach, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102865 · Cited by 32
“Leukotriene B4 (LTB4) plays its role in amplification and propagation of inflammation [24] acting in concert with the peptide Interleukin 8 (IL8) as a potent neutrophil chemo-attractant [25,26].”
BackgroundPlatelet‐conditioned media induces an anti‐inflammatory macrophage phenotype through EP4
Heffron, S. P., Weinstock, A., Scolaro, B., Chen, S., Sansbury, B. E., Marecki, G., Rolling, C. C., Bannoudi, H. E., Barrett, T. J., Canary, J. W., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15172 · Cited by 35
Shoieb, S. M., El‐Ghiaty, M. A., & El‐Kadi, A. O. S. (2020) · Emergent Materials · doi:10.1007/s42247-020-00136-8 · Cited by 27
Resolvins: Potent Pain Inhibiting Lipid Mediators via Transient Receptor Potential Regulation
Roh, J., Go, E. J., Park, J., Kim, Y. H., & Park, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.584206 · Cited by 33
“These mediators bind to pain receptors expressed in nociceptors (Woolf, 2010; Lim et al., 2015).”
BackgroundUlu, A., Burr, A., Heires, A. J., Pavlik, J. A., Larsen, T. D., Perez, P. A., Bravo, C., DiPatrizio, N. V., Baack, M. L., Romberger, D. J., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108797 · Cited by 32
“SPMs are produced in response to a “temporal lipid mediator class switch”, which initiates the resolution phase of acute inflammation [63,64].”
BackgroundArtru, F., McPhail, M. J. W., Triantafyllou, E., & Trovato, F. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867261 · Cited by 32
“Through their binding to the GPCRs and PPARs, prostanoids exert various effects such as modulation of vascular tone (vasodilatation and vascular leakage), IL-10 and TNFa levels (7, 17, 18), T cell activation (19), mast cell maturation (20), eosinophilic recruitment and allergic response (21), increase in adipogenesis…”
BackgroundMolecular Pharmacology of Inflammation Resolution in Atherosclerosis
Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 34
“High concentrations of rosiglitazone and pioglitazone significantly increased lipopolysaccharide-stimulated production of prostanoids such as TXA2 and PGE2 [271].”
BackgroundResolvin D1 prevents injurious neutrophil swarming in transplanted lungs
Li, W., Shepherd, H. M., Terada, Y., Shay, A. E., Bery, A. I., Gelman, A. E., Lavine, K. J., Serhan, C. N., & Kreisel, D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302938120 · Cited by 27
“In mouse grafts, we observed that the lipid mediator class switch occurs early after lung transplantation with transient increases in LTB 4 levels soon after reperfusion and sustained elevation of RvD1 levels until at least day 7 (20, 21).”
Self-citationLin, P., LIN, Y.-J., Lee, C., Liu, H., & LEE, J.-C. (2013) · Oncology Letters · doi:10.3892/ol.2013.1426 · Cited by 30
“The mechanism of COX-2 induction in these tumors is not fully understood, however, COX-2 expression may be stimulated by proinflammatory cytokines, growth factors, tumor promoters or mutagenic substances under inflammatory and tumor growth conditions (9,10).”
Resolvin E1 as a novel agent for the treatment of asthma
Hisada, T., Ishizuka, T., Aoki, H., & Mori, M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902865622 · Cited by 29
Gyurko, R., & Dyke, T. E. V. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014009982 · Cited by 31
Mechanisms Mediating Reduced Responsiveness of Neonatal Neutrophils to Lipoxin A4
Weinberger, B. I., Quizon, C., Vetrano, A. M., Archer, F. E., Laskin, J. D., & Laskin, D. L. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318180e4af · Cited by 29
“Prolonged exposure to pro-inflammatory mediators such as PGE2 triggers the generation of lipoxin A4 and the downregulation of neutrophilic inflammation (24).”
InfluentialAnti-inflammatory pathways as a host evasion mechanism for pathogens
Aliberti, J., & Báfica, A. L. B. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.018 · Cited by 27
“Although the molecular basis for 5-lipoxygenase induction after parasite stimulation has not been clarified, it is known that this enzyme can be induced after leukocyte exposure to a variety of stimuli, including PGE2 [32].”
BackgroundThe eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn
Nicolaou, A., Masoodi, M., Gledhill, K., Haylett, A. K., Thody, A. J., Tobin, D. J., & Rhodes, L. E. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05272a · Cited by 27
Moges, R., de Lamache, D. D., Sajedy, S., RENAUX, B. S., Hollenberg, M. D., Muench, G. P., Abbott, E. M., & Buret, A. G. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00057 · Cited by 29
Cakin, M. C., Özdemir, B., Dağıstanlı, F. K., Arkan, H., Bahtiyar, N., Anapalı, M., Akbaş, F., & Onaran, İ. (2019) · Platelets · doi:10.1080/09537104.2019.1663805 · Cited by 27
“The bioactive lipids have been shown to regulate the inflammatory response and proliferation during wound healing [13,14].”
BackgroundThe Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation
Martinez, R. M., Fattori, V., Saito, P., Pinto, I. C., Rodrigues, C. C. A., Melo, C. P. B., Bussmann, A. J. C., Staurengo‐Ferrari, L., Bezerra, J. R., Vignoli, J. A., et al. (2020) · Molecules · doi:10.3390/molecules25122953 · Cited by 30
“Rather than a passive process, the current concept is that SPMs, such as Lipoxins (LX), Maresins (MaR), Protectins (PD), and Resolvins (Rv) actively orchestrate the resolution of inflammation [9,10].”
BackgroundAnderson, P. O., & Delgado, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00387.x · Cited by 36
“Both PGE2 and PGD2 activate the expression of 15-LOX in neutrophils, which switches the mediator profile of these cells from LTB4 to lipoxins [122].”
BackgroundTargeting hypoxia–A2A adenosine receptor-mediated mechanisms of tissue protection
Lukashev, D. E., Ohta, A., & Sitkovsky, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03044-2 · Cited by 30
Wong, C., Stoilova, I., Gazeau, F., Herbeuval, J., & Fourniols, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355845 · Cited by 30
Saczuk, K., Dudek, M., Matczyszyn, K., & Deiana, M. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00186a · Cited by 26
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives
Vomero, M., Lamberti, L., Corberi, E., Currado, D., Marino, A., Berardicurti, O., Fava, M., Leuti, A., Maccarrone, M., Giacomelli, R., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103896 · Cited by 30
Wang, R. X., & Colgan, S. P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.002 · Cited by 30
“Appropriately termed a lipid mediator class switch, resolution begins with a transition from the proinflammatory prostaglandins and leukotrienes to the pro-resolving SPMs consisting of the resolvins, lipoxins, protectins, and maresins (Levy et al., 2001).”
BackgroundZolk, O., Häfner, S., & Schmidt, C. Q. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01890-6 · Cited by 43
Mastromarino, M., Lacivita, E., Colabufo, N. A., & Leopoldo, M. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200719014433 · Cited by 29
Neuroimmune communication in infection and pain: Friends or foes?
Fattori, V., Ferraz, C. R., Rasquel-Oliveira, F. S., & Verri, W. A., Jr. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.11.009 · Cited by 28
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.